A program needs a control group the moment you want to claim it caused an outcome, not just that the outcome happened. If you're reporting how many people enrolled, how satisfied they were, or how a number moved between intake and exit, you don't need one yet — that's a description of what occurred. The moment "because" enters the sentence — participants improved because of the program — you need something to compare against, because almost everything else that could produce the same before/after number is still sitting there unaccounted for.
A comparison group isn't bureaucratic overhead; it's the only way to separate the program's effect from everything else that changes a number over time. Without one, at least four explanations are competing with "the program worked" for the same data: participants who were doing unusually badly when they enrolled tend to improve somewhat on their own (regression to the mean); people mature, learn, or recover regardless of intervention; broader trends — a better job market, a new policy, a seasonal effect — move the outcome for everyone, participants or not; and the people who sign up for a voluntary program are usually not a random slice of the population, so their trajectory was never going to match anyone else's. A control group — a genuinely comparable group that didn't get the program — is what lets you subtract those explanations out and see what's left.
Randomizing who gets a program is often the cleanest design and sometimes the right call, but it isn't always ethical or feasible — you can't randomly deny a service people are entitled to, or a waitlist may not exist. In those cases, a weaker but still genuine comparison is usually available: a staggered or phased rollout that lets early cohorts serve as a comparison for later ones, a matched comparison group built from people who look similar on the variables that predict the outcome, a difference-in-differences design comparing the change in participants against the change in a similar untreated group over the same period, or a regression discontinuity design when eligibility is decided by a cutoff score or threshold. None of these are as clean as a randomized trial, but all of them beat a single before/after number, because they at least attempt to answer what would have happened anyway.
The risk isn't just a weaker report — it's a specific one. Programs that look effective on a before/after number and then get evaluated with a real comparison group have, more than once, turned out to have no effect or a negative one, after everyone involved was already convinced otherwise. That's a harder conversation to have after three years of reporting the wrong number than before you started.
If you're scoping a program evaluation and aren't sure what kind of comparison group is realistic given your constraints, that's exactly the design question we help sort out early, before the data collection locks you into an answer you can't fully trust.
One email whenever we publish something new. No spam, unsubscribe anytime.
{{ subscribeErrorMsg }}